Cargando…
Clinicians’ Perspectives on Barriers and Facilitators for the Adoption of Non-Invasive Liver Tests for NAFLD: A Mixed-Method Study
(1) Background: Given the high prevalence of non-alcoholic fatty liver disease (NAFLD) and the limitations of liver biopsies, multiple non-invasive tests (NITs) have been developed to identify non-alcoholic fatty liver disease (NAFLD) patients at-risk of progression. The availability of these new NI...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146541/ https://www.ncbi.nlm.nih.gov/pubmed/35628838 http://dx.doi.org/10.3390/jcm11102707 |
_version_ | 1784716588586369024 |
---|---|
author | Vali, Yasaman Eijk, Roel Hicks, Timothy Jones, William S. Suklan, Jana Holleboom, Adriaan G. Ratziu, Vlad Langendam, Miranda W. Anstee, Quentin M. Bossuyt, Patrick M. M. |
author_facet | Vali, Yasaman Eijk, Roel Hicks, Timothy Jones, William S. Suklan, Jana Holleboom, Adriaan G. Ratziu, Vlad Langendam, Miranda W. Anstee, Quentin M. Bossuyt, Patrick M. M. |
author_sort | Vali, Yasaman |
collection | PubMed |
description | (1) Background: Given the high prevalence of non-alcoholic fatty liver disease (NAFLD) and the limitations of liver biopsies, multiple non-invasive tests (NITs) have been developed to identify non-alcoholic fatty liver disease (NAFLD) patients at-risk of progression. The availability of these new NITs varies from country to country, and little is known about their implementation and adoption in routine clinical practice. This study aims to explore barriers and facilitators that influence the adoption of NAFLD NITs, from healthcare professionals’ perspectives. (2) Methods: A cross-sectional study was performed using an exploratory mixed-methods approach. Twenty-seven clinicians from eight different countries with different specialties filled in our questionnaire. Of those, 16 participated in semi-structured interviews. Qualitative and quantitative data were collected and summarized using the recently published Non-adoption, Abandonment, Scale-up, Spread, and Sustainability (NASSS) framework for new medical technologies in healthcare organizations. (3) Results: Several factors were reported as influencing the uptake of NITs for NAFLD in clinical practice. Among those: insufficient awareness of tests; lack of practical guidelines and evidence for the performance of tests in appropriate patient populations and care settings; and absence of sufficient reimbursement systems were reported as the most important barriers. Other factors, most notably ‘local champions’, proper functional payment systems, and sufficient resources in academic hospitals, were indicated as important facilitating factors. (4) Conclusions: Clinicians see the adoption of NITs for NAFLD as a complex process that is modulated by several factors, such as robust evidence, practical guidelines, a proper payment system, and local champions. Future research could explore perspectives from other stakeholders on the adoption of NITs. |
format | Online Article Text |
id | pubmed-9146541 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91465412022-05-29 Clinicians’ Perspectives on Barriers and Facilitators for the Adoption of Non-Invasive Liver Tests for NAFLD: A Mixed-Method Study Vali, Yasaman Eijk, Roel Hicks, Timothy Jones, William S. Suklan, Jana Holleboom, Adriaan G. Ratziu, Vlad Langendam, Miranda W. Anstee, Quentin M. Bossuyt, Patrick M. M. J Clin Med Article (1) Background: Given the high prevalence of non-alcoholic fatty liver disease (NAFLD) and the limitations of liver biopsies, multiple non-invasive tests (NITs) have been developed to identify non-alcoholic fatty liver disease (NAFLD) patients at-risk of progression. The availability of these new NITs varies from country to country, and little is known about their implementation and adoption in routine clinical practice. This study aims to explore barriers and facilitators that influence the adoption of NAFLD NITs, from healthcare professionals’ perspectives. (2) Methods: A cross-sectional study was performed using an exploratory mixed-methods approach. Twenty-seven clinicians from eight different countries with different specialties filled in our questionnaire. Of those, 16 participated in semi-structured interviews. Qualitative and quantitative data were collected and summarized using the recently published Non-adoption, Abandonment, Scale-up, Spread, and Sustainability (NASSS) framework for new medical technologies in healthcare organizations. (3) Results: Several factors were reported as influencing the uptake of NITs for NAFLD in clinical practice. Among those: insufficient awareness of tests; lack of practical guidelines and evidence for the performance of tests in appropriate patient populations and care settings; and absence of sufficient reimbursement systems were reported as the most important barriers. Other factors, most notably ‘local champions’, proper functional payment systems, and sufficient resources in academic hospitals, were indicated as important facilitating factors. (4) Conclusions: Clinicians see the adoption of NITs for NAFLD as a complex process that is modulated by several factors, such as robust evidence, practical guidelines, a proper payment system, and local champions. Future research could explore perspectives from other stakeholders on the adoption of NITs. MDPI 2022-05-11 /pmc/articles/PMC9146541/ /pubmed/35628838 http://dx.doi.org/10.3390/jcm11102707 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Vali, Yasaman Eijk, Roel Hicks, Timothy Jones, William S. Suklan, Jana Holleboom, Adriaan G. Ratziu, Vlad Langendam, Miranda W. Anstee, Quentin M. Bossuyt, Patrick M. M. Clinicians’ Perspectives on Barriers and Facilitators for the Adoption of Non-Invasive Liver Tests for NAFLD: A Mixed-Method Study |
title | Clinicians’ Perspectives on Barriers and Facilitators for the Adoption of Non-Invasive Liver Tests for NAFLD: A Mixed-Method Study |
title_full | Clinicians’ Perspectives on Barriers and Facilitators for the Adoption of Non-Invasive Liver Tests for NAFLD: A Mixed-Method Study |
title_fullStr | Clinicians’ Perspectives on Barriers and Facilitators for the Adoption of Non-Invasive Liver Tests for NAFLD: A Mixed-Method Study |
title_full_unstemmed | Clinicians’ Perspectives on Barriers and Facilitators for the Adoption of Non-Invasive Liver Tests for NAFLD: A Mixed-Method Study |
title_short | Clinicians’ Perspectives on Barriers and Facilitators for the Adoption of Non-Invasive Liver Tests for NAFLD: A Mixed-Method Study |
title_sort | clinicians’ perspectives on barriers and facilitators for the adoption of non-invasive liver tests for nafld: a mixed-method study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146541/ https://www.ncbi.nlm.nih.gov/pubmed/35628838 http://dx.doi.org/10.3390/jcm11102707 |
work_keys_str_mv | AT valiyasaman cliniciansperspectivesonbarriersandfacilitatorsfortheadoptionofnoninvasivelivertestsfornafldamixedmethodstudy AT eijkroel cliniciansperspectivesonbarriersandfacilitatorsfortheadoptionofnoninvasivelivertestsfornafldamixedmethodstudy AT hickstimothy cliniciansperspectivesonbarriersandfacilitatorsfortheadoptionofnoninvasivelivertestsfornafldamixedmethodstudy AT joneswilliams cliniciansperspectivesonbarriersandfacilitatorsfortheadoptionofnoninvasivelivertestsfornafldamixedmethodstudy AT suklanjana cliniciansperspectivesonbarriersandfacilitatorsfortheadoptionofnoninvasivelivertestsfornafldamixedmethodstudy AT holleboomadriaang cliniciansperspectivesonbarriersandfacilitatorsfortheadoptionofnoninvasivelivertestsfornafldamixedmethodstudy AT ratziuvlad cliniciansperspectivesonbarriersandfacilitatorsfortheadoptionofnoninvasivelivertestsfornafldamixedmethodstudy AT langendammirandaw cliniciansperspectivesonbarriersandfacilitatorsfortheadoptionofnoninvasivelivertestsfornafldamixedmethodstudy AT ansteequentinm cliniciansperspectivesonbarriersandfacilitatorsfortheadoptionofnoninvasivelivertestsfornafldamixedmethodstudy AT bossuytpatrickmm cliniciansperspectivesonbarriersandfacilitatorsfortheadoptionofnoninvasivelivertestsfornafldamixedmethodstudy |